|
|
|
市場調査レポート
医薬品賦形剤市場
Excipients in Pharmaceuticals
| 発行 |
BCC Research |
| 出版日 |
2009年09月 |
商品コード |
90900 |
| ページ情報 |
英文 283 pages |
| 価格 |
|
|
当商品の販売は、2011年08月19日を持ちまして終了しました。
アップデート版はこちらになります。
Excipients in Pharmaceuticals
出版日: 2011年08月
商品コード: 208748
Abstract
THIS REPORT WILL:
- Provide a detailed analysis of the excipients market today and a forecast
of what the market will look like in 5 years
- Offer information on inert ingredients, the types of technologies used to
make them, their uses, and regulatory influences
- Highlight excipients by chemical compounds, functional uses, delivery
systems and finished products
- Report on a global supply-chain crisis, which prominently involves
excipients; hundreds of people have died in several countries because of
adulterated pharmaceutical materials from China, and the crisis will take
years to fix
- Profile leading industry participants.
INTRODUCTION
REASONS FOR THE STUDY
Powerful forces affect the global excipients industry in 2009, including a
crisis in the global supply chain, the demands of Quality by Design (QbD),
worries about drug safety, new legislation in the offing, a need for new
excipients, exciting ideas for unlocking the industry' s creativity, and new
levels of cooperation between major players (e.g., Dow and Colorcon). These
forces are reshaping the business rapidly. In addition, as if these factors
were not enough, companies are also contending with a nasty recession.
Up-to-date information is essential for competitors.
GOALS AND OBJECTIVES
The primary goals of this technical/market report are to provide a detailed
analysis of the excipients market today and a forecast of what the market will
look like in 5 years. The specific objectives (1) identify excipients being
used; (2) quantify global market volume; (3) track important developments; (4)
analyze the structure of the industry and its driving forces; (5) examine the
most active companies and describe how they respond to market demands; and (6)
provide data with which the reader can further evaluate the industry.
INTENDED AUDIENCE
As a market and technology summary, this report consolidates a wide range of
industrial and technical information that should aid excipient suppliers,
chemical companies, drug manufacturers, healthcare regulators, and
congressional staffers keep current with today' s marketplace. The report
should be of value to companies interested in entering or expanding their
involvement in the field. The report should provide senior marketing personnel
and executive planners with insight about what materials can best satisfy
customer demands. Market projections may be of interest to venture capitalists
interested in exploring commercialization opportunities, as well as companies
and personnel involved in designing and constructing chemical and excipient
manufacturing plants and/or those who service such plants. The report offers
useful background to consultants in the field. The report can serve as an
introductory resource for newcomers to the business, including new employees.
In addition, the report can offer background to governmental officials
examining reform.
SCOPE OF REPORT
Excipients in Pharmaceuticals offers coverage of the most important issues
surrounding excipients: technological, regulatory, economic, political, and so
on.
Excluded from the study are ingredients for cosmetics, personal care, food,
quasi-medical, unorthodox, alternative, home remedies, underground and/or
illegal drugs, and veterinary drugs.
This report organizes information from diverse sources into sections entitled
Summary, Overview, Technology, Industry Structure, and Company Profiles. The
Summary encapsulates several key conclusions and includes a table of market
findings. The Overview provides deep background on the burning issues of the
day, including the global supply chain crisis, QbD, and legislative prospects.
The Technology section examines excipients by chemical compounds, functional
uses, and delivery systems, and as finished products. The Industry Structure
section discusses the market environment, strategies, influences, market
shares, international aspects, and other related factors. The Company Profiles
segment provides summaries of more than 120 companies that supply excipients
or are relevant to the industry.
METHODS AND SOURCES
The methodology used to create Excipients in Pharmaceuticals included
extensive telephone interviews with key executives of leading U.S. and
European companies and consultancies. This commentary was combined with
information gleaned from websites, annual reports, the trade press, textbooks,
patents, press releases, and government documents.
The information has been used to project and forecast market size, and
calculate compound annual growth rates (CAGRs) of the overall market and many
market segments. All market sizes refer to worldwide values and volumes, which
are rounded to the nearest million in dollars and lbs. Market size is
estimated at the manufacturer level; that is, the level of consumption in
actual drug formulations. Where precise information was not available, a
consensus was made using a formulation of reasonable assumptions and estimates
based on historical data. In this report, the market size for 2008 serves as a
base for making estimates for 2009 and projections to 2014.
Table of Contents
Chapter- 1: INTRODUCTION -- Complimentary 3
- REASON FOR THE STUDY 1
- GOALS AND OBJECTIVES 1
- AUDIENCE 1
- SCOPE OF REPORT 2
- METHODS AND SOURCES 2
- ANALYST CREDENTIALS 2
- RELATED BCC REPORTS 3
- BCC ONLINE SERVICES 3
- DISCLAIMER 3
Chapter-2: SUMMARY 6
- SUMMARY TABLE GLOBAL EXCIPIENT MARKET BY MATERIAL TYPE, THROUGH 2014 ($
MILLIONS) 4
- SUMMARY FIGURE GLOBAL EXCIPIENT MARKET, 2009 AND 2014 ($ MILLIONS) 5
- SUMMARY (CONTINUED) 6
- SUMMARY (CONTINUED) 7
- SUMMARY (CONTINUED) 8
- SUMMARY (CONTINUED) 9
Chapter-3: OVERVIEW 31
- MR. BLECHER' S LETTER 10
- WHAT IS AN EXCIPIENT? 11
- WHAT IS AN EXCIPIENT? (CONTINUED) 12
- THE PHARMACEUTICALS INDUSTRY IN TURMOIL: 2000 TO TODAY 12
- THE PHARMACEUTICALS INDUSTRY ...(CONTINUED) 13
- THE KNOWLEDGE CRISIS 14
- THE KNOWLEDGE CRISIS (CONTINUED) 15
- THE KNOWLEDGE CRISIS (CONTINUED) 16
- THE NEED FOR NEW EXCIPIENTS 17
- THE NEED FOR NEW EXCIPIENTS (CONTINUED) 18
- A NOTE ABOUT DIRECT COMPRESSION 19
- COPROCESSING IS SPLENDID, BUT IT IS NOT ENOUGH 20
- QBD AND THE GLOBAL SUPPLY CHAIN CRISIS: TWO TIDAL WAVES 21
- HOW AND WHY THE QUALITY APPROACH CAME TO PHARMA 22
- HOW AND WHY THE QUALITY ...(CONTINUED) 23
- HOW AND WHY THE QUALITY ...(CONTINUED) 24
- HOW AND WHY THE QUALITY ...(CONTINUED) 25
- THE BASICS OF QBD IN 1,000 WORDS 26
- THE BASICS OF QBD IN 1,000 WORDS (CONTINUED) 27
- THE BASICS OF QBD IN 1,000 WORDS (CONTINUED) 28
- THE GLOBAL SUPPLY CHAIN CRISIS 29
- THE GLOBAL SUPPLY CHAIN CRISIS (CONTINUED) 30
- THE GLOBAL SUPPLY CHAIN CRISIS (CONTINUED) 31
- CHRONOLOGY, PART II 32
- CHRONOLOGY, PART II (CONTINUED) 33
- CHRONOLOGY, PART II (CONTINUED) 34
- CHRONOLOGY, PART II (CONTINUED) 35
- CHRONOLOGY, PART II (CONTINUED) 36
- IS THE WORKFORCE UP TO IT? 37
- A NOTE ON THE RECESSION 38
- THE REGULATORY SCENE 38
- THE REGULATORY SCENE (CONTINUED) 39
- THE REGULATORY SCENE (CONTINUED) 40
Chapter-4: GLOBAL EXCIPIENT MARKET: SEVERAL BASIC FIGURES 7
- FIGURE 1 GLOBAL EXCIPIENT MARKET SHARE BY CATEGORY OF MATERIAL, 2009 (%) 41
- FIGURE 2 GLOBAL EXCIPIENT MARKET SHARE BY TYPE OF ORGANIC CHEMICAL, 2009
(%) 42
- FIGURE 3 GLOBAL EXCIPIENT MARKET SHARE BY TYPE OF INORGANIC CHEMICAL, 2009
(%) 43
- FIGURE 4 GLOBAL EXCIPIENT MARKET SHARE BY TYPE OF USP WATER, 2009 (%) 44
- FIGURE 5 GLOBAL EXCIPIENT MARKET SHARE BY FUNCTIONAL USE, 2009 (%) 45
- FIGURE 6 GLOBAL EXCIPIENT MARKET SHARE BY TYPE OF DELIVERY SYSTEM, 2009
(%) 46
- FIGURE 7 GLOBAL EXCIPIENT MARKET FOR FINISHED PRODUCTS BY TYPE (RX AND
OTC), 2009 (%) 47
Chapter-5: CHEMICAL COMPOUNDS 157
- CHEMICAL COMPOUNDS 48
- MARKET SIZE 49
- TABLE 1 GLOBAL EXCIPIENT MARKET VALUE BY MATERIAL TYPE, THROUGH 2014 ($
MILLIONS) 49
- TABLE 2 GLOBAL EXCIPIENT MARKET VOLUME BY MATERIAL TYPE, THROUGH 2014 (LBS
MILLIONS) 50
- ORGANIC CHEMICALS 50
- MARKET SIZE FOR ORGANIC CHEMICALS 50
- TABLE 3 GLOBAL ORGANIC CHEMICAL EXCIPIENT MARKET VALUE BY TYPE, THROUGH
2014 ($ MILLIONS) 51
- TABLE 4 GLOBAL ORGANIC CHEMICAL EXCIPIENT MARKET VOLUME BY TYPE, THROUGH
2014 (LBS MILLIONS) 51
- CARBOHYDRATES 51
- Market Size 51
- TABLE 5 GLOBAL CARBOHYDRATE EXCIPIENT MARKET BY TYPE, THROUGH 2014 ($
MILLIONS) 52
- TABLE 6 GLOBAL CARBOHYDRATE EXCIPIENT MARKET BY TYPE, THROUGH 2014 (LBS
MILLIONS) 52
- Celluloses 52
- Market Size 53
- TABLE 7 GLOBAL CELLULOSE EXCIPIENT MARKET BY TYPE, THROUGH 2014 ($
MILLIONS) 53
- TABLE 8 GLOBAL CELLULOSE EXCIPIENT MARKET BY TYPE, THROUGH 2014 (LBS
MILLIONS) 53
- Microcrystalline Cellulose 53
- Market Size 54
- TABLE 9 GLOBAL MCC EXCIPIENT MARKET, THROUGH 2014 ($ MILLIONS/LBS
MILLIONS) 54
- Cellulose Ethers 54
- Market Size 55
- TABLE 10 GLOBAL CELLULOSE ETHER EXCIPIENT MARKET, THROUGH 2014 ($
MILLIONS/LBS MILLIONS) 55
- Cellulose Esters 55
- Market Size 55
- TABLE 11 GLOBAL CELLULOSE ESTER EXCIPIENT MARKET, THROUGH 2014 ($
MILLIONS/LBS MILLIONS) 56
- Carboxymethyl Cellulose and Croscarmellose Sodium 56
- Market Size 57
- TABLE 12 GLOBAL CMC AND CROSCARMELLOSE EXCIPIENT MARKET, THROUGH 2014 ($
MILLIONS/LBS MILLIONS) 57
- Sugars 57
- Market Size 57
- TABLE 13 GLOBAL SUGAR EXCIPIENT MARKET BY TYPE, THROUGH 2014 ($ MILLIONS)
58
- TABLE 14 GLOBAL SUGAR EXCIPIENT MARKET BY TYPE, THROUGH 2014 (MILLION LBS)
58
- Actual Sugars 58
- Market Size 58
- TABLE 15 GLOBAL ACTUAL SUGAR EXCIPIENT MARKET BY TYPE, THROUGH 2014 ($
MILLIONS) 59
- TABLE 16 GLOBAL ACTUAL SUGAR EXCIPIENT MARKET BY TYPE, THROUGH 2014 (LBS
MILLIONS) 59
- Lactose 59
- Market Size 60
- TABLE 17 GLOBAL LACTOSE EXCIPIENT MARKET, THROUGH 2014 ($ MILLIONS/LBS
MILLIONS) 60
- Sucrose 60
- Market Size 60
- TABLE 18 GLOBAL SUCROSE EXCIPIENT MARKET, THROUGH 2014 ($ MILLIONS/LBS
MILLIONS) 61
- Dextrose (Glucose) 61
- Market Size 61
- TABLE 19 GLOBAL DEXTROSE (GLUCOSE) EXCIPIENT MARKET, THROUGH 2014 ($
MILLIONS/LBS MILLIONS) 61
- Sugar Alcohols 61
- Market Size 62
- TABLE 20 GLOBAL SUGAR ALCOHOL (POLYOL) EXCIPIENT MARKET BY TYPE, THROUGH
2014 ($ MILLIONS) 62
- TABLE 21 GLOBAL SUGAR ALCOHOL (POLYOL) EXCIPIENT MARKET BY TYPE, THROUGH
2014 (LBS MILLIONS) 62
- Sorbitol 62
- Market Size 63
- TABLE 22 GLOBAL SORBITOL EXCIPIENT MARKET, THROUGH 2014 ($ MILLIONS/LBS
MILLIONS) 63
- Mannitol 63
- Market Size 63
- TABLE 23 GLOBAL MANNITOL EXCIPIENT MARKET, THROUGH 2014 ($ MILLIONS/LBS
MILLIONS) 64
- Other Sugar Alcohols 64
- Market Size 64
- TABLE 24 GLOBAL OTHER SUGAR ALCOHOL EXCIPIENT MARKET, THROUGH 2014 ($
MILLIONS/LBS MILLIONS) 64
- Maltitol 65
- Xylitol 65
- Erythritol 65
- Isomalt 65
- Tagatose 66
- Trehalose 66
- Artificial Sweeteners 66
- Market Size 66
- TABLE 25 GLOBAL ARTIFICIAL SWEETENER EXCIPIENT MARKET, THROUGH 2014 ($
MILLIONS/LBS MILLIONS) 67
- Aspartame 67
- Neotame 67
- Acesulfame-K 68
- Saccharin 68
- Sucralose 68
- Starches 69
- Market Size 69
- TABLE 26 GLOBAL STARCHES EXCIPIENT MARKET BY TYPE, THROUGH 2014 ($
MILLIONS) 69
- TABLE 27 GLOBAL STARCHES EXCIPIENT MARKET BY TYPE, THROUGH 2014 (LBS
MILLIONS) 70
- Dried Starch 70
- Market Size 70
- TABLE 28 GLOBAL DRIED STARCH EXCIPIENT MARKET, THROUGH 2014 ($
MILLIONS/LBS MILLIONS) 70
- Modified Starch 71
- Market Size 71
- TABLE 29 GLOBAL MODIFIED STARCH EXCIPIENT MARKET, THROUGH 2014 ($
MILLIONS/LBS MILLIONS) 71
- Converted Starch 71
- Market Size 72
- TABLE 30 GLOBAL CONVERTED STARCH EXCIPIENT MARKET, THROUGH 2014 ($
MILLIONS/LBS MILLIONS) 72
- PETROCHEMICALS 72
- Market Size 72
- TABLE 31 GLOBAL PETROCHEMICAL EXCIPIENT MARKET BY TYPE, THROUGH 2014 ($
MILLIONS) 73
- TABLE 32 GLOBAL PETROCHEMICAL EXCIPIENT MARKET BY TYPE, THROUGH 2014 (LBS
MILLIONS) 73
- Glycols 73
- Market Size 74
- TABLE 33 GLOBAL GLYCOL EXCIPIENT MARKET BY TYPE, THROUGH 2014 ($ MILLIONS)
74
- TABLE 34 GLOBAL GLYCOL EXCIPIENT MARKET BY TYPE, THROUGH 2014 (LBS
MILLIONS) 74
- Polyethylene Glycol 74
- Market Size 75
- TABLE 35 GLOBAL PEG EXCIPIENT MARKET, THROUGH 2014 ($ MILLIONS/LBS
MILLIONS) 75
- Propylene Glycol 75
- Market Size 75
- TABLE 36 GLOBAL PG EXCIPIENT MARKET, THROUGH 2014 ($ MILLIONS/LBS
MILLIONS) 76
- Povidones 76
- Market Size 76
- TABLE 37 GLOBAL PVP EXCIPIENT MARKET, THROUGH 2014 ($ MILLIONS/LBS
MILLIONS) 77
- Mineral Hydrocarbons 77
- Market Size 77
- TABLE 38 GLOBAL MINERAL HYDROCARBON EXCIPIENT MARKET BY TYPE, THROUGH 2014
($ MILLIONS) 77
- TABLE 39 GLOBAL MINERAL HYDROCARBON EXCIPIENT MARKET BY TYPE, THROUGH 2014
(LBS MILLIONS) 78
- Petrolatum 78
- Market Size 78
- TABLE 40 GLOBAL PETROLATUM EXCIPIENT MARKET, THROUGH 2014 ($ MILLIONS/LBS
MILLIONS) 79
- Mineral Waxes 79
- Market Size 79
- TABLE 41 GLOBAL MINERAL WAX EXCIPIENT MARKET, THROUGH 2014 ($ MILLIONS/LBS
MILLIONS) 79
- Mineral Oils 80
- Market Size 80
- TABLE 42 GLOBAL MINERAL OIL EXCIPIENT MARKET, THROUGH 2014 ($ MILLIONS/LBS
MILLIONS) 80
- Acrylic Polymers 80
- Market Size 81
- TABLE 43 GLOBAL ACRYLIC EXCIPIENT MARKET, THROUGH 2014 ($ MILLIONS/LBS
MILLIONS) 81
- Other Petrochemical Materials 81
- Market Size 81
- TABLE 44 GLOBAL OTHER PETROCHEMICAL EXCIPIENT MARKET, THROUGH 2014 ($
MILLIONS/LBS MILLIONS) 82
- Antimicrobials 82
- Antioxidants 82
- Dyes and Lakes 82
- TABLE 45 SYNTHETIC COLORANTS IN PHARMACEUTICALS 83
- EDTA 84
- Flavors 84
- Glycine and Glycylglycine 84
- Vinyl Polymers 84
- Silicones 85
- Miscellaneous Synthetic Petrochemicals 85
- OLEOCHEMICALS 85
- Market Size 86
- TABLE 46 GLOBAL OLEOCHEMICAL EXCIPIENT MARKET BY TYPE, THROUGH 2014 ($
MILLIONS) 86
- TABLE 47 GLOBAL OLEOCHEMICAL EXCIPIENT MARKET BY TYPE, THROUGH 2014 (LBS
MILLIONS) 86
- Fatty Alcohols 87
- Market Size 87
- TABLE 48 GLOBAL FATTY ALCOHOL EXCIPIENT MARKET, THROUGH 2014 ($
MILLIONS/LBS MILLIONS) 87
- Glycerin 87
- Market Size 88
- TABLE 49 GLOBAL GLYCERIN EXCIPIENT MARKET, THROUGH 2014 ($ MILLIONS/LBS
MILLIONS) 88
- Metal Stearates 88
- Market Size 88
- TABLE 50 GLOBAL METAL STEARATE EXCIPIENT MARKET, THROUGH 2014 ($
MILLIONS/LBS MILLIONS) 89
- Other Oleochemicals 89
- Market Size 89
- TABLE 51 GLOBAL OTHER OLEOCHEMICAL EXCIPIENT MARKET, THROUGH 2014 ($
MILLIONS/LBS MILLIONS) 89
- Natural Waxes 89
- Beeswax 90
- Candelilla Wax 90
- Carnauba Wax 90
- Cocoa and Shea Butters 90
- Lanolin 90
- Phospholipids 91
- Sodium Lauryl Sulfate 91
- Sorbitan 91
- Synthetic Glyceryl Esters 91
- Vegetable Oils 91
- PROTEINS 92
- Gelatin 92
- Market Size 92
- TABLE 52 GLOBAL PROTEINS (GELATIN) EXCIPIENT MARKET, THROUGH 2014 ($
MILLIONS/LBS MILLIONS) 93
- Albumin 93
- OTHER ORGANIC CHEMICALS 93
- TABLE 53 GLOBAL OTHER ORGANIC CHEMICAL EXCIPIENT MARKET, THROUGH 2014 ($
MILLIONS/LBS MILLIONS) 94
- Alcohols 94
- Citric Acid 94
- Lactic Acid 95
- Polysaccharide Gums 95
- Shellac 95
- INORGANIC CHEMICALS 95
- MARKET SIZE 95
- TABLE 54 GLOBAL INORGANIC CHEMICAL EXCIPIENT MARKET BY TYPE, THROUGH 2014
($ MILLIONS/LBS MILLIONS) 96
- TABLE 55 GLOBAL INORGANIC CHEMICAL EXCIPIENT MARKET BY TYPE, THROUGH 2014
(LBS MILLIONS) 96
- CALCIUM SALTS 96
- Market Size 96
- TABLE 56 GLOBAL CALCIUM SALT EXCIPIENT MARKET BY TYPE, THROUGH 2014 ($
MILLIONS) 97
- TABLE 57 GLOBAL CALCIUM SALT EXCIPIENT MARKET BY TYPE, THROUGH 2014 (LBS
MILLIONS) 97
- Calcium Phosphate 97
- Market Size 98
- TABLE 58 GLOBAL CALCIUM PHOSPHATE EXCIPIENT MARKET, THROUGH 2014 ($
MILLIONS/LBS MILLIONS) 98
- Calcium Carbonate 98
- Market Size 99
- TABLE 59 GLOBAL CALCIUM CARBONATE EXCIPIENT MARKET, THROUGH 2014 ($
MILLIONS/LBS MILLIONS) 99
- Calcium Sulfate 99
- Market Size 99
- TABLE 60 GLOBAL CALCIUM SULFATE EXCIPIENT MARKET, THROUGH 2014 ($
MILLIONS/LBS MILLIONS) 100
- HALITES 100
- Market Size 100
- TABLE 61 GLOBAL HALITE EXCIPIENT MARKET, THROUGH 2014 ($ MILLIONS/LBS
MILLIONS) 100
- METAL OXIDES 101
- Market Size 101
- TABLE 62 GLOBAL METAL OXIDE EXCIPIENT MARKET BY TYPE, THROUGH 2014 ($
MILLIONS) 101
- TABLE 63 GLOBAL METAL OXIDE EXCIPIENT MARKET BY TYPE, THROUGH 2014 (LBS
MILLIONS) 101
- Titanium Dioxide 101
- Market Size 102
- TABLE 64 GLOBAL TIO2 EXCIPIENT MARKET, THROUGH 2014 ($ MILLIONS/LBS
MILLIONS) 102
- Iron Oxide 102
- Market Size 102
- TABLE 65 GLOBAL IRON OXIDE EXCIPIENT MARKET THROUGH 2014 ($ MILLIONS/LBS
MILLIONS) 103
- SILICATES 103
- Market Size 103
- TABLE 66 GLOBAL SILICATES EXCIPIENT MARKET BY TYPE, THROUGH 2014 ($
MILLIONS) 103
- TABLE 67 GLOBAL SILICATES EXCIPIENT MARKET BY TYPE, THROUGH 2014 (LBS
MILLIONS) 104
- Silicon Dioxide 104
- Market Size 104
- TABLE 68 GLOBAL SILICON DIOXIDE EXCIPIENT MARKET, THROUGH 2014 ($
MILLIONS/LBS MILLIONS) 105
- Talc 105
- Market Size 105
- TABLE 69 GLOBAL TALC EXCIPIENT MARKET, THROUGH 2014 ($ MILLIONS/LBS
MILLIONS) 106
- Clay 106
- Market Size 106
- TABLE 70 GLOBAL CLAY EXCIPIENT MARKET, THROUGH 2014 ($ MILLIONS/LBS
MILLIONS) 106
- OTHER INORGANIC CHEMICALS 107
- Market Size 107
- TABLE 71 GLOBAL OTHER INORGANIC CHEMICAL EXCIPIENT MARKET, THROUGH 2014 ($
MILLIONS/LBS MILLIONS) 107
- USP WATER (PHARMACEUTICAL WATER) 107
- MARKET SIZE 108
- TABLE 72 GLOBAL USP WATER EXCIPIENT MARKET, THROUGH 2014 ($ MILLIONS) 108
- TABLE 73 GLOBAL USP WATER EXCIPIENT MARKET, THROUGH 2014 (LBS MILLIONS) 108
- WATER FOR INJECTIONS 108
- Market Size 109
- TABLE 74 GLOBAL USP WFI EXCIPIENT MARKET, THROUGH 2014 ($ MILLIONS/LBS
MILLLIONS) 109
- PURIFIED WATER 109
- Market Size 109
- TABLE 75 GLOBAL USP PURIFIED WATER EXCIPIENT MARKET, THROUGH 2014 ($
MILLIONS/LBS MILLLIONS) 110
- FUNCTIONAL USES 110
- TABLE 76 GLOBAL EXCIPIENT FUNCTIONAL USES MARKET BY TYPE, THROUGH 2014 ($
MILLIONS) 111
- TABLE 77 GLOBAL EXCIPIENT FUNCTIONAL USES MARKET BY TYPE, THROUGH 2014
(LBS MILLIONS) 111
- FILLERS 112
- MARKET SIZE 112
- TABLE 78 GLOBAL EXCIPIENT FILLER MARKET BY TYPE, THROUGH 2014 ($ MILLIONS)
112
- TABLE 79 GLOBAL EXCIPIENT FILLER MARKET VOLUME BY TYPE, THROUGH 2014 (LBS
MILLIONS) 113
- EMOLLIENTS 113
- MARKET SIZE 113
- TABLE 80 GLOBAL EMOLLIENTS EXCIPIENT MARKET, THROUGH 2014 ($ MILLIONS/LBS
MILLIONS) 114
- VEHICLES 114
- MARKET SIZE 114
- TABLE 81 GLOBAL VEHICLE EXCIPIENT MARKET BY TYPE, THROUGH 2014 ($
MILLIONS) 115
- TABLE 82 GLOBAL VEHICLE EXCIPIENT MARKET BY TYPE, THROUGH 2014 (LBS
MILLIONS) 115
- COATINGS 116
- MARKET SIZE 116
- TABLE 83 GLOBAL COATINGS EXCIPIENT MARKET BY TYPE, THROUGH 2014 ($
MILLIONS) 116
- TABLE 84 GLOBAL COATINGS EXCIPIENT MARKET BY TYPE, THROUGH 2014 (LBS
MILLIONS) 117
- DISINTEGRANTS 118
- MARKET SIZE 118
- TABLE 85 GLOBAL SUPERDISINTEGRANT EXCIPIENT MARKET BY TYPE, THROUGH 2014
($ MILLIONS) 118
- TABLE 86 GLOBAL SUPERDISINTEGRANT EXCIPIENT MARKET BY TYPE, THROUGH 2014
(LBS MILLIONS) 119
- FLAVORS 119
- MARKET SIZE 119
- TABLE 87 GLOBAL FLAVORS EXCIPIENT MARKET VALUE BY TYPE, THROUGH 2014 ($
MILLIONS) 120
- TABLE 88 GLOBAL FLAVORS EXCIPIENT MARKET VOLUME BY TYPE, THROUGH 2014 (LBS
MILLIONS) 120
- TABLE 89 COMPARISON OF SEVERAL SWEETENERS TO SUCROSE (%) 121
- TONICITY AGENTS 121
- MARKET SIZE 121
- TABLE 90 GLOBAL TONICITY AGENT EXCIPIENT MARKET VALUE, THROUGH 2014 ($
MILLIONS) 121
- TABLE 91 GLOBAL TONICITY AGENT EXCIPIENT MARKET VOLUME, THROUGH 2014 (LBS
MILLIONS) 122
- COLORANTS 122
- MARKET SIZE 122
- TABLE 92 GLOBAL COLORANTS EXCIPIENT MARKET BY TYPE, THROUGH 2014 ($
MILLIONS) 123
- TABLE 93 GLOBAL COLORANTS EXCIPIENT MARKET VOLUME BY TYPE, THROUGH 2014
(LBS MILLIONS) 123
- OTHER FUNCTIONAL USES 123
- MARKET SIZE 123
- TABLE 94 GLOBAL MARKET FOR OTHER FUNCTIONAL USES, THROUGH 2014 ($
MILLIONS/LBS MILLIONS) 124
- PERFUMES 124
- BINDERS 124
- BUFFERS 125
- CHELATING AGENTS 125
- COMPRESSION AIDS 125
- EMULSIFIERS 125
- FOAM CONTROL AGENTS 126
- GLIDANTS 126
- HUMECTANTS 126
- LUBRICANTS 126
- PLASTICIZERS 127
- PRESERVATIVES 127
- THICKENERS 127
- DELIVERY SYSTEMS 128
- MARKET SIZE 128
- TABLE 95 GLOBAL EXCIPIENT DELIVERY SYSTEMS MARKET BY TYPE, THROUGH 2014 ($
MILLIONS) 128
- TABLE 96 GLOBAL EXCIPIENT DELIVERY SYSTEMS MARKET BY TYPE, THROUGH 2014
(LBS MILLIONS) 129
- FIGURE 8 GLOBAL EXCIPIENT DELIVERY SYSTEMS MARKET BY TYPE, 2009 AND 2014
(%) 129
- FIGURE 8 (CONTINUED) 130
- INJECTION 130
- TABLE 97 TYPICAL INJECTION COMPOSITION (%) 130
- MARKET SIZE 131
- TABLE 98 GLOBAL EXCIPIENTS FOR INJECTIONS MARKET VALUE BY FUNCTION,
THROUGH 2014 ($ MILLIONS) 131
- TABLE 99 GLOBAL EXCIPIENTS FOR INJECTIONS MARKET VOLUME BY FUNCTION,
THROUGH 2014 (LBS MILLIONS) 131
- ORAL 132
- MARKET SIZE 132
- TABLE 100 GLOBAL EXCIPIENTS IN ORAL DELIVERY SYSTEMS MARKET BY TYPE,
THROUGH 2014 ($ MILLIONS) 133
- TABLE 101 GLOBAL EXCIPIENTS IN ORAL DELIVERY SYSTEMS MARKET BY TYPE,
THROUGH 2014 (LBS MILLIONS) 133
- SOLIDS 133
- MARKET SIZE 133
- TABLE 102 GLOBAL EXCIPIENTS IN ORAL SOLID DELIVERY SYSTEMS MARKET BY TYPE,
THROUGH 2014 ($ MILLIONS) 134
- TABLE 103 GLOBAL EXCIPIENTS IN ORAL SOLID DELIVERY SYSTEMS MARKET BY TYPE,
THROUGH 2014 (LBS MILLIONS) 134
- TABLETS 134
- TABLE 104 TYPICAL TABLET COMPOSITION 135
- MARKET SIZE 136
- TABLE 105 GLOBAL EXCIPIENTS IN TABLETS MARKET BY FUNCTION, THROUGH 2014 ($
MILLIONS) 136
- TABLE 106 GLOBAL EXCIPIENTS IN TABLETS MARKET BY FUNCTION, THROUGH 2014
(LBS MILLIONS) 137
- Market Size (Continued) 138
- CAPSULES 139
- MARKET SIZE 139
- TABLE 107 GLOBAL EXCIPIENTS IN GELATIN CAPSULES MARKET BY TYPE, THROUGH
2014 ($ MILLIONS) 139
- TABLE 108 GLOBAL EXCIPIENTS IN GELATIN CAPSULES MARKET BY TYPE, THROUGH
2014 (LBS MILLIONS) 140
- HARD GELATIN CAPSULES 140
- TABLE 109 TYPICAL HARD GELATIN CAPSULE COMPOSITION 140
- Market Size 141
- TABLE 110 GLOBAL EXCIPIENTS IN HARD GELATIN CAPSULES MARKET VALUE BY
FUNCTION, THROUGH 2014 ($ MILLIONS) 141
- TABLE 111 GLOBAL EXCIPIENTS IN HARD GELATIN CAPSULES MARKET VOLUME BY
FUNCTION, THROUGH 2014 (LBS MILLIONS) 141
- SOFT GELATIN CAPSULES 142
- TABLE 112 TYPICAL SOFT GELATIN CAPSULE COMPOSITION 142
- Market Size 142
- TABLE 113 GLOBAL EXCIPIENTS IN SOFT GELATIN CAPSULES MARKET VALUE BY
FUNCTION, THROUGH 2014 ($ MILLIONS) 143
- TABLE 114 GLOBAL EXCIPIENTS IN SOFT GELATIN CAPSULES MARKET VOLUME BY
FUNCTION, THROUGH 2014 (LBS MILLIONS) 143
- LIQUIDS 144
- TABLE 115 TYPICAL LIQUID COMPOSITION (%) 144
- MARKET SIZE 144
- TABLE 116 GLOBAL EXCIPIENTS IN LIQUIDS MARKET VALUE BY FUNCTION, THROUGH
2014 ($ MILLIONS) 145
- TABLE 117 GLOBAL EXCIPIENTS IN LIQUIDS MARKET VOLUME BY FUNCTION, THROUGH
2014 (LBS MILLIONS) 145
- TOPICAL DELIVERY SYSTEMS 146
- MARKET SIZE 146
- TABLE 118 GLOBAL EXCIPIENTS IN TOPICAL DELIVERY SYSTEMS BY TYPE, THROUGH
2014 ($ MILLIONS) 147
- TABLE 119 GLOBAL EXCIPIENTS IN TOPICAL DELIVERY SYSTEMS BY TYPE, THROUGH
2014 (LBS MILLIONS) 147
- TABLE 120 TYPICAL OINTMENT COMPOSITION (%) 148
- CREAMS AND GELS 148
- TABLE 121 TYPICAL CREAM COMPOSITION (%) 148
- LOTIONS 149
- TABLE 122 TYPICAL TOPICAL LOTION COMPOSITION (%) 149
- DERMAL POWDERS 150
- SOLUTIONS 150
- ADVANCED DELIVERY SYSTEMS 150
- MARKET SIZE 151
- TABLE 123 GLOBAL EXCIPIENT ADVANCED DELIVERY SYSTEMS VALUE BY FUNCTION,
THROUGH 2014 ($ MILLIONS) 151
- TABLE 124 GLOBAL EXCIPIENT ADVANCED DELIVERY SYSTEMS VOLUME BY FUNCTION,
THROUGH 2014 (LBS MILLIONS) 151
- TABLE 124 (CONTINUED) 152
- CYCLODEXTRINS 152
- HYDROGELS 152
- IMPLANTS 152
- LIPOSOMES 152
- MICROPARTICLES 153
- MICROSPHERES 153
- NANOTECHNOLOGY (NANOPARTICLES) 153
- Nanotechnology (nanoparticles) (Continued) 154
- Nanotechnology (nanoparticles) (Continued) 155
- OSMOTIC PUMPS 156
- TRANSDERMAL 156
- TRANSMUCOSAL 157
- Buccal 157
- Tablets 157
- Capsules 158
- Lozenges 158
- Particles 159
- Thin Strips 159
- Inhalation 160
- Nasal 160
- Pulmonary 160
- Ophthalmic 161
- Otic 162
- Rectal 162
- Vaginal 163
- FINISHED PRODUCTS 163
- Market Size 163
- TABLE 125 GLOBAL EXCIPIENTS IN FINISHED PRODUCTS BY TYPE, THROUGH 2014 ($
MILLIONS) 164
- TABLE 126 GLOBAL EXCIPIENTS IN FINISHED PRODUCTS BY TYPE, THROUGH 2014
(LBS MILLIONS) 165
- PRESCRIPTION PRODUCTS 165
- MARKET SIZE 165
- TABLE 127 GLOBAL EXCIPIENTS IN RX DRUGS BY DELIVERY SYSTEM, THROUGH 2014
($ MILLIONS) 166
- TABLE 128 GLOBAL EXCIPIENTS IN RX DRUGS BY DELIVERY SYSTEM, THROUGH 2014
(LBS MILLIONS) 166
- INJECTIONS 166
- Market Size 167
- TABLE 129 GLOBAL EXCIPIENTS IN INJECTED RX DRUGS BY TYPE, THROUGH 2014 ($
MILLIONS) 167
- TABLE 130 GLOBAL EXCIPIENTS IN INJECTED RX DRUGS BY TYPE, THROUGH 2014
(LBS MILLIONS) 167
- Small Molecule Drug Injections 167
- TABLE 131 GLOBAL EXCIPIENTS IN INJECTED RX SMALL MOLECULE DRUGS MARKET,
THROUGH 2014 ($ MILLIONS/LBS MILLIONS) 168
- Biologic Drug Injections 168
- TABLE 132 GLOBAL EXCIPIENTS IN INJECTED RX BIOLOGIC DRUGS MARKET, THROUGH
2014 ($ MILLIONS/LBS MILLIONS) 169
- Protein Drugs 169
- Vaccines 170
- ORAL 170
- Market Size 170
- TABLE 133 GLOBAL EXCIPIENTS IN ORAL RX DRUGS MARKET, THROUGH 2014 ($
MILLIONS/LBS MILLIONS) 171
- TOPICAL 172
- TABLE 134 GLOBAL EXCIPIENTS IN TOPICAL RX DRUGS MARKET, THROUGH 2014 ($
MILLIONS/LBS MILLIONS) 172
- ADVANCED DRUG DELIVERY SYSTEMS 172
- TABLE 135 GLOBAL EXCIPIENTS IN ADVANCED SYSTEMS FOR RX DRUGS MARKET,
THROUGH 2014 ($ MILLIONS/LBS MILLIONS) 172
- OVER-THE-COUNTER PRODUCTS 173
- MARKET SIZE 173
- TABLE 136 GLOBAL EXCIPIENTS IN OTC FINISHED PRODUCTS VALUE BY DELIVERY
SYSTEM, THROUGH 2014 ($ MILLIONS) 174
- TABLE 137 GLOBAL EXCIPIENTS IN OTC FINISHED PRODUCTS VOLUME BY DELIVERY
SYSTEM, THROUGH 2014 (LBS MILLIONS) 174
- FINISHED PRODUCT TRENDS 174
- PHARMACOGENOMICS 175
- COUNTERFEIT/STOLEN DRUGS 175
- INDUSTRY STRUCTURE 175
- INDUSTRY ENVIRONMENT 176
- MARKET INFLUENCES 176
- Pharmaceutical Industry Pressures 176
- General Health Trends 177
- Healthcare Industry 177
- Consumer Demographics 178
- IMPORTANT STRATEGIES 178
- R&D SPENDING 178
- CONSUMER ADVERTISING 178
- LEGISLATIVE LOBBYING 179
- CONSOLIDATION 179
- MULTIPLICITY OF DELIVERY SYSTEMS 179
- SUPPLIER LISTS 179
- QUALITY BY DESIGN 180
- MATERIAL CHOICE DECISIONS 180
- DRIVING FORCES 180
- MARKET SHARES 181
- FIGURE 9 SIMPLIFIED INDUSTRY STRUCTURE 181
- RAW MATERIAL SUPPLIERS 181
- Organic Chemical Suppliers 182
- Carbohydrate Suppliers 182
- Cellulose Suppliers 182
- FIGURE 10 MARKET SHARE OF MAJOR CELLULOSE SUPPLIERS, 2009 (%) 182
- FIGURE 10 (CONTINUED) 183
- Sugar Suppliers 183
- Actual Sugar Suppliers 183
- FIGURE 11 MARKET SHARE OF ACTUAL SUGAR EXCIPIENT SUPPLIERS, 2009 (%) 183
- FIGURE 11 (CONTINUED) 184
- Sugar Alcohols (Polyols) 184
- FIGURE 12 MARKET SHARE OF MAJOR SUGAR ALCOHOL (POLYOL) EXCIPIENT
SUPPLIERS, 2009 (%) 185
- Artificial Sweeteners 185
- Starch Suppliers 186
- FIGURE 13 MARKET SHARE OF MAJOR STARCH EXCIPIENT SUPPLIERS, 2009 (%) 186
- FIGURE 13 (CONTINUED) 187
- Protein Suppliers 187
- FIGURE 14 MARKET SHARE OF MAJOR PROTEIN (GELATIN) EXCIPIENT SUPPLIERS,
2009 (%) 188
- Petrochemical Suppliers 188
- Glycol Suppliers 189
- FIGURE 15 MARKET SHARE OF MAJOR GLYCOL EXCIPIENT SUPPLIERS, 2009 (%) 189
- PVP Suppliers 190
- Mineral Hydrocarbon Suppliers 190
- Acrylic Suppliers 190
- Oleochemical Suppliers 190
- FIGURE 16 MARKET SHARE OF MAJOR OLEOCHEMICAL EXCIPIENT SUPPLIERS, 2009 (%)
191
- Inorganic Chemical Suppliers 192
- Calcium Salts Suppliers 192
- FIGURE 17 MARKET SHARE OF MAJOR CALCIUM-BASED EXCIPIENT SUPPLIERS, 2009
(%) 192
- Halite Suppliers 193
- FIGURE 18 MARKET SHARE OF MAJOR HALITE EXCIPIENT SUPPLIERS, 2009 (%) 193
- FIGURE 18 (CONTINUED) 194
- Metal Oxide Suppliers 194
- FIGURE 19 MARKET SHARE OF MAJOR METAL OXIDE EXCIPIENT SUPPLIERS, 2009 (%)
194
- FIGURE 19 (CONTINUED) 195
- Silicate Suppliers 195
- USP Water Suppliers 195
- FIGURE 20 MARKET SHARE OF MAJOR USP WATER SUPPLIERS, 2009 (%) 196
- DISTRIBUTORS/MODIFIERS 197
- Distributors 197
- TABLE 138 DISTRIBUTOR CATEGORIES 197
- Brokers 198
- Import/Export Traders 198
- Chemical Stocking/Repacking 198
- Modifiers 198
- TABLE 139 CATEGORIES OF MODIFIERS 199
- Contract Development Organizations 199
- Contract Coaters 199
- END USERS 199
- TABLE 140 CATEGORIES OF MODIFIERS 200
- Drug Companies 200
- Contract Formulators 200
- Retail and Hospital Pharmacies 201
- Pharmacy Colleges and Other Academic Institutions 201
- Other End Users 201
- INTERNATIONAL ASPECTS 202
- Americas 202
- Europe 202
- Asia/Pacific Rim 203
- Others 204
Chapter-6: COMPANY PROFILES 79
- COMPANY PROFILES 205
- COMPANY PROFILES (CONTINUED) 206
- ABBOTT LABORATORIES 207
- ADAMAS PHARMACEUTICALS, INC. 208
- ADM (ARCHER DANIELS MIDLAND CO.) 208
- AKZO NOBEL N.V. (ALSO ICI AND NATIONAL STARCH) 209
- AMERICHEM PHARMACEUTICAL CORP. 210
- AMTEX (QUIMICA AMTEX MEXICO) 210
- ARLA FOODS A.M.B.A. 211
- ASAHI KASEI CORP. (ASAHI KASEI PHARMA) 211
- ASHLAND AQUALON FUNCTIONAL INGREDIENTS (AAFI) 212
- ASSOCIATED BRITISH FOODS (ABF) 213
- BANNER PHARMACAPS, INC. 214
- BASF A.G. 215
- BAXTER INTERNATIONAL, INC. 216
- BLANVER FARMOQUIMICA, LTDA. 217
- BLUE REFERENCE 217
- BRENNTAG GROUP 218
- BUDENHEIM 218
- CABOT CORP. 219
- CALUMET SPECIALTY PRODUCTS PARTNERS, LP (PENRECO) 219
- CARGILL, INC. 220
- CHARLES TENNANT & CO., LTD. 221
- CHR. HANSEN A/S 221
- COGNIS DEUTSCHLAND GMBH & CO. K.G. 222
- COLORCON, INC. 223
- CORN PRODUCTS INTERNATIONAL, INC. 224
- COSMETIC SPECIALTIES, INC. 225
- CRISTAL GLOBAL (NATIONAL TITANIUM DIOXIDE CO., LTD.) 225
- CRODA INTERNATIONAL, PLC 225
- CRODA INTERNATIONAL, PLC (CONTINUED) 226
- CSL BEHRING, LLC 227
- CSM N.V. 227
- CTD, INC. 228
- CYDEX PHARMACEUTICALS, INC. 228
- DANISCO A/S 229
- DOW CHEMICAL CO. 230
- DOW CHEMICAL CO. (CONTINUED) 231
- DUPONT (E.I. DU PONT DE NEMOURS & CO.) 232
- EASTMAN CHEMICAL CO. 233
- EM2 SOLUTIONS, INC. 234
- EURAND 234
- EVONIK DEGUSSA GMBH (EVONIK INDUSTRIES AG) 234
- FERRO CORP. 235
- FIBROGEN, INC. 236
- FINNBRIT CONSULTING 236
- FLAVORX INC. 236
- FMC CORP. 237
- FMC CORP. (CONTINUED) 238
- FONTERRA CO-OPERATIVE GROUP, LTD. 239
- FOREMOST FARMS USA 240
- FUJI HEALTH SCIENCE, INC. (FUJI CHEMICAL INDUSTRY CO., LTD.) 241
- GATTEFOSSE GROUP 241
- GE HEALTHCARE 242
- GELITA AG 242
- GENERAL CHEMICAL (GENCHEM) 243
- GLATT GMBH (GLATT AIR TECHNIQUES, INC.) 243
- GRAIN PROCESSING CORP. 243
- GRIFOLS S.A. (LABORATORIOS GRIFOLS S.A.) 244
- GTC BIOTHERAPEUTICS, INC. 245
- HILMAR CHEESE CO. (HILMAR INGREDIENTS) 245
- HOLLANDSE MELKSUIKERFABRIEK 245
- IMERYS 246
- INTERNATIONAL SPECIALTY PRODUCTS (ISP) 246
- J.M. HUBER CORP. (CP KELCO AND HUBER ENGINEERED MATERIALS) 247
- CP KELCO 247
- HUBER ENGINEERED MATERIALS 247
- JOHNSON & JOHNSON PHARMACEUTICAL R&D 248
- JOST CHEMICAL CO. 249
- JRS PHARMA (AND J. RETTENMAIER) 249
- KEMIRA OYJ 250
- KOSTER KEUNEN HOLLAND B.V. 251
- KRAFT FOODS ATLANTIC GELATIN 251
- KRONOS WORLDWIDE, INC. 251
- LANXESS A.G. 252
- LUBRIZOL CORP. 252
- LYONDELLBASELL INDUSTRIES 252
- MALLINCKRODT BAKER, INC. (COVIDIEN) 253
- MEGGLE GMBH 254
- MERCK KGAA (AND EMD) 255
- MICRO-MACINAZIONE S.A. 256
- MINERALS TECHNOLOGIES, INC. (SPECIALTY MINERALS, INC.) 256
- MINGTAI CHEMICAL CO., LTD. 257
- MITSUBISHI CHEMICAL PERFORMANCE POLYMERS, INC. 257
- MUTCHLER, INC. PHARMACEUTICAL INGREDIENTS 258
- NITTA GELATIN, INC. 258
- NORDZUCKER AG 259
- NOVOZYMES A/S 259
- NUSIL TECHNOLOGY 260
- NUTRASWEET CO. 260
- OMYA A.G. 261
- PARAYTEC, LTD. 262
- PERRIGO CO. 262
- PFIZER, INC. 262
- P&G CHEMICALS 263
- PHARMACEUTICAL-TECHNOLOGY.COM 263
- PMC GLOBAL, INC. 263
- PURDUE PHARMA, LP 264
- QUALITY SYSTEMS DESIGN, INC. 264
- RHODIA S.A. 265
- RIO TINTO, PLC 265
- ROQUETTE FRERES 266
- ROUSSELOT S.A.S. 267
- ROYAL FRIESLANDCAMPINA N.V. 268
- R.T. VANDERBILT COMPANY, INC. 269
- RUGER CHEMICAL CO., INC. 269
- SASOL, LTD. ADR 270
- SCHERING-PLOUGH CORP. 270
- SENSIENT TECHNOLOGIES CORP. 271
- SEPPIC S.A. 271
- SHEFFIELD PHARMA INGREDIENTS 272
- SHELL CHEMICALS (ROYAL DUTCH SHELL) 273
- SHIN-ETSU CHEMICAL CO., LTD. 273
- SOLVAY S.A. 274
- SPI PHARMA, INC. 275
- STEPAN CO. 275
- STERLING BIOTECH, LTD. 276
- TABLETS & CAPSULES 276
- TAKEHARA CHEMICAL INDUSTRIAL CO., LTD. 277
- TALECRIS BIOTHERAPEUTICS, INC. 277
- TATE & LYLE, PLC 277
- TATE & LYLE, PLC (CONTINUED) 278
- TESSENDERLO GROUP (PB GELATINS) 279
- TOMITA PHARMACEUTICAL CO., LTD. 279
- UNIVAR N.V. (AND UNIVAR USA) 280
- USG CORP. 280
- VALIDATION & ENGINEERING GROUP (VEG) 280
- VERTELLUS PERFORMANCE MATERIALS, INC. (VPMI) 281
- WACKER FINE CHEMICALS (WACKER CHEMIE) 281
- WEI MING PHARMACEUTICAL MFG. CO., LTD. 282
- WEISHARDT GROUP 282
- W.R. GRACE & CO. 283
|
 |
